Biotech · Private company · New York, NY, US
ILiAD Biotechnologies
Track this companyFree. Adds ILiAD Biotechnologies to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- BPZE1 pertussis vaccine and VaxINator(TM) Atomization DevicePhase 2 · PertussisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy AdultsPHASE2 · COMPLETED · started Jun 15, 2019ClinicalTrials.gov NCT03942406 · fetched Nov 12, 2026
NIH awards1
- Live nasal recombinant B. pertussis vaccine against tuberculosisFiscal year 2024 · $317.5KNIH RePORTER 5R61AI169201-03 · fetched Nov 12, 2026